Latigo Biotherapeutics, Inc. IPO Review

Latigo Biotherapeutics, Inc. IPO Pages

πŸ“

Detailed review coming soon

Our editorial team is preparing an in-depth analysis of Latigo Biotherapeutics, Inc. IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.

Price / Issue Price
$18
Issue Size
$345 M
Type
Mainboard
Exchange
Nasdaq
Already listed.